FDA Inspection 1204500 — Thomas Jefferson University Hospital

Thomas Jefferson University Hospital — FEI 2572826

The FDA completed an inspection of Thomas Jefferson University Hospital on April 18, 2023 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 18, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Philadelphia, PA (United States)